Pages

Tuesday, October 30, 2018

US FDA News: FDA takes action to stop the use of lead acetate in hair dyes

FDA takes action to stop the use of lead acetate in hair dyes. FDA will no longer allow lead acetate to be used in certain hair coloring products based on data that demonstrate that there is no longer a reasonable certainty of no harm from the use of this color additive.
Read more: FDA takes action to stop the use of lead acetate in hair dyes

Monday, October 29, 2018

Pharma Reviews: India to create a vibrant startup eco-system and Russia will actively partner in setting up incubation ...

Commerce Minister said that Russia can be a valuable market in ... India's pharma exports to Russia constitute a sizable chunk but possibilities of joint ...
Read more: India to create a vibrant startup eco-system and Russia will actively partner in setting up incubation ...

Pharma Reviews: Shaily Engineering Plastics: Investment-worthy at current levels

The company's clientele includes some of the world's most well-known ... After seeking approvals from a US-based medical company, Shaily aims to earn ... low due to slower-than-anticipated demand from Indian pharma companies.
Read more: Shaily Engineering Plastics: Investment-worthy at current levels

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new consideration of labeling for sesame allergies

Food allergies have touched the lives of most of us. Thousands of Americans experience life-threatening, food-related reactions each year, and an estimated 20 people die from them annually. In some cases, such reactions occur despite a careful reading of packaged food labels by conscientious consumers. To me, that’s unacceptable. The FDA is committed to advancing our efforts to help ensure that Americans have access to the information they need about common allergens in packaged foods.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new consideration of labeling for sesame allergies

Sunday, October 28, 2018

Pharma Reviews: The digital supply chain is not just about compliance; it's also about business value and optimization.

While the Indian government requires Indian pharmaceutical companies to comply with the Drug Authentication Verification Application (DAVA) ...
Read more: The digital supply chain is not just about compliance; it's also about business value and optimization.

Pharma Reviews: Laminated Pills

The Indian pharma industry is commendable, in being able to supply medication (though most be branded generics) to the vast population of this ...
Read more: Laminated Pills

Pharma Reviews: Big pharma cos set to return to double-digit growth this fiscal: Crisil

Big pharma cos set to return to double-digit growth this fiscal: Crisil ... After two consecutive years of single-digit expansion, big Indian drug firms ... listed drug-makers, which account for three-fourths of the pharma industry revenue.
Read more: Big pharma cos set to return to double-digit growth this fiscal: Crisil

Pharma Reviews: Big Pharma Firms To Grow In Double Digits In FY19, Says Crisil

Big Pharma Firms To Grow In Double Digits In FY19, Says Crisil ... After two consecutive years of single-digit expansion, big Indian drug firms are ... listed drugmakers, which account for three-fourths of the pharma industry revenue.
Read more: Big Pharma Firms To Grow In Double Digits In FY19, Says Crisil

Pharma Reviews: Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL

The return to double-digit growth would help the homegrown pharma companies, with turnover of Rs 10 billion or more, to weather a sharp rise in ...
Read more: Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL

Pharma Reviews: Crisil says Indian pharma companies will witness strong growth this fiscal

After two consecutive years of single-digit expansion, big Indian drug firms are expected to return to double-digit growth in the current fiscal aided by a ...
Read more: Crisil says Indian pharma companies will witness strong growth this fiscal

Pharma Reviews: Big pharma companies set to return to double-digit growth this fiscal: Crisil

NEW DELHI: After two consecutive years of single-digit expansion, big Indian drug firms are expected to return to double-digit growth in the current ...
Read more: Big pharma companies set to return to double-digit growth this fiscal: Crisil

Saturday, October 27, 2018

Pharma Reviews: A case for branded generics

Making a mark in the global market, India is the largest provider of generic drugs globally. Today, the Indian pharmaceutical sector industry supplies ...
Read more: A case for branded generics

Pharma Reviews: Bitter pill

According to some estimates, the Indian drug market has over 70,000 formulations, created from a basic number of around 750 active pharmaceutical ...
Read more: Bitter pill

Pharma Reviews: Professor Bhupinder Singh to be conferred with pharma fellowship award

Panjab University's Professor Bhupinder Singh Bhoop has been selected for prestigious "Fellowship Award of the Indian Pharmaceutical Association ...
Read more: Professor Bhupinder Singh to be conferred with pharma fellowship award

Pharma Reviews: PU professor to be conferred with prestigious pharma fellowship award

... "Fellowship Award of the Indian Pharmaceutical Association (ÌPA)" for the ... Sciences (2014-17), Dean, Faculty of Pharmaceutical Sciences, Panjab ...
Read more: PU professor to be conferred with prestigious pharma fellowship award

Pharma Reviews: 'Banned ingredients in diet pills putting Indians at risk'

Often to circumvent drug price regulation or stringent pharmaceutical norms, companies tweak their pharma formulations and launch their products as ...
Read more: 'Banned ingredients in diet pills putting Indians at risk'

Wednesday, October 24, 2018

US FDA News: FDA approves new drug to treat influenza

FDA approved Xofluza (baloxavir marboxil) to treat acute uncomplicated flu in patients 12 years old and older who have been symptomatic for less than 48 hours.
Read more: FDA approves new drug to treat influenza

Tuesday, October 23, 2018

Pharma Reviews: Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on Wednesday

Zydus Cadila is the country's fourth-largest Indian pharmaceutical company with ... The original plan was to sell only the Indian operations and brands.
Read more: Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on Wednesday

Pharma Reviews: Indian pharma industry to grow at 7-9 pct between 2018-21: Report

Indian companies have gained adequate scale and drug development capabilities over the last decade of growth.
Read more: Indian pharma industry to grow at 7-9 pct between 2018-21: Report

Pharma Reviews: Pharma sector to post moderate 7-9% CAGR due to healthy demand

Indian companies have gained adequate scale and drug development capabilities over last decade of growth which will keep them in good stead to ...
Read more: Pharma sector to post moderate 7-9% CAGR due to healthy demand

Pharma Reviews: Pharma sector growth to moderate at 7-9% CAGR for FY 2018-21

The growth trajectory for the Indian pharmaceutical industry is likely to be moderate at 7-9% over FY2018 to FY2021, on the back of healthy demand ...
Read more: Pharma sector growth to moderate at 7-9% CAGR for FY 2018-21

Pharma Reviews: Gujarat's pharma sector to draw Rs 6-9000 crore investment

This will provide a significant boost to pharma production in the state,” said Viranchi Shah, chairman, Gujarat State Board, Indian Drug Manufacturers' ...
Read more: Gujarat's pharma sector to draw Rs 6-9000 crore investment

Friday, October 19, 2018

Pharma Reviews: FII View | Foreign investors cautious on India, pharma & consumption attractive: Steven Birch

Stocks are in good health, the manufacturing facilities of Biocon, Cipla have come clear with USFDA inspection. Indian pharma firms can benefit from ...
Read more: FII View | Foreign investors cautious on India, pharma & consumption attractive: Steven Birch

Pharma Reviews: SCHOTT Tubing India to further 20 million euros in India

SCHOTT AG, a global pioneer in manufacturing pharmaceutical glass and packaging, has announced the launch of a new glass tank in its Indian ...
Read more: SCHOTT Tubing India to further 20 million euros in India

Thursday, October 18, 2018

US FDA News: Trump Administration Launches “Winning on Reducing Food Waste” Initiative

The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA) today announced the signing of a joint agency formal agreement under the "Winning on Reducing Food Waste" initiative.
Read more: Trump Administration Launches “Winning on Reducing Food Waste” Initiative

Pharma Reviews: Intellectual Property Policy Can Boost Both Innovation and Access to Medicines

India's policy framework started off by supporting the growth of the domestic pharma industry that espoused reverse-engineering methods to mass ...
Read more: Intellectual Property Policy Can Boost Both Innovation and Access to Medicines

Pharma Reviews: India: The Sunshine Sector In "Make In India" – Medical Device Industry Shines As Never Before

With the rapidly expanding Indian pharmaceutical and healthcare sector over the years, the growth in demand for advanced and innovative medical ...
Read more: India: The Sunshine Sector In "Make In India" – Medical Device Industry Shines As Never Before

Tuesday, October 16, 2018

Pharma Reviews: El Salvador eyes Indian investors

El Salvador is keen to attract investments from Indian companies in the energy, ITeS, pharma, manufacturing and textiles sectors, the Central ...
Read more: El Salvador eyes Indian investors

Pharma Reviews: Tycoon Piramal Weighs $1 Billion Contract Pharma Sale

(Bloomberg) -- Indian tycoon Ajay Piramal is considering a sale of his contract pharmaceutical operations, which could fetch around $1 billion, people ...
Read more: Tycoon Piramal Weighs $1 Billion Contract Pharma Sale

Pharma Reviews: Insolvency code helps, but investors may turn cautious as election nears

The pharma sector was also active during the quarter, recording eight deals worth $1.3 ... Another deal in the sector was Constellation Alpha Capital Corp's ... marking the largest investment in an Indian diagnostics company till date.
Read more: Insolvency code helps, but investors may turn cautious as election nears

Monday, October 15, 2018

Pharma Reviews: India & Korea ink MoU to promote Medical Devices Sector

In a bid to further provide an impetus and boost Indian & Korean Medical Device Industry, The Association of Indian Medical Device Industry (AiMeD) ...
Read more: India & Korea ink MoU to promote Medical Devices Sector

Pharma Reviews: Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%

Shares of pharmaceutical were in focus in an otherwise subdued market on ... Natco Pharma, Morepen Laboratories, Granules India and Sequent ...
Read more: Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%

Pharma Reviews: How technology is evolving healthcare industry, offering a patient-centric experience

Counterfeit drugs are one of the most critical issues prevailing in the Indian pharmaceutical industry that can put the patients at a higher risk. Hence ...
Read more: How technology is evolving healthcare industry, offering a patient-centric experience

Sunday, October 14, 2018

Pharma Reviews: Pharmaceuticals Q2FY19 preview: Quarter likely to see muted performance

We expect Indian Pharma to report 9% y-o-y revenue growth and 100bps margin drop ... For Sun Pharma, specialty launch spend remains the key. ... for the overall industry (213 in Q2FY19 vs 208 in Q1FY19) and Indian companies.
Read more: Pharmaceuticals Q2FY19 preview: Quarter likely to see muted performance

Saturday, October 13, 2018

Pharma Reviews: Drug makers may have to pay 5 times more for pharma imports

... and get their overseas manufacturing facilities audited by the Indian regulator. The move aims to increase domestic manufacturing of medicines.
Read more: Drug makers may have to pay 5 times more for pharma imports

Friday, October 12, 2018

Pharma Reviews: ePHARMACIES' TIME HAS COME

Over the past few years, the Indian pharma sector has been gaining traction largely owing to some of the key regulatory and policy changes that have ...
Read more: ePHARMACIES' TIME HAS COME

Pharma Reviews: OPPI advocates for policies that promote scientific temperament

The Organisation of Pharmaceutical Producers of India (OPPI) celebrated their 52nd Annual Day recently. Themed #HealthMeetsHope, the Chief ...
Read more: OPPI advocates for policies that promote scientific temperament

Pharma Reviews: Indian pharma market grows 9.7% in Q2FY19 on uptake across therapy segments

The Indian pharmaceutical market (IPM) grew at 9.7 percent in the second quarter ended September, according to market research firm ...
Read more: Indian pharma market grows 9.7% in Q2FY19 on uptake across therapy segments

Thursday, October 11, 2018

US FDA News: FDA approves new DNA-based test to determine blood compatibility

FDA approves new DNA-based test to determine blood compatibility.Test is first of this type approved to report genotypes as final results
Read more: FDA approves new DNA-based test to determine blood compatibility

Wednesday, October 10, 2018

Pharma Reviews: What changed for the market while you were sleeping? Top 10 things to know

The Dow Jones Industrial Average fell 56.21 points, or 0.21 percent, ... Over-dependence of Indian pharma industry on imported raw materials from ...
Read more: What changed for the market while you were sleeping? Top 10 things to know

Tuesday, October 9, 2018

Pharma Reviews: Govt working on plan to raise API production to cut Chinese dependence: Comm Min report

Over-dependence of Indian pharma industry on imported raw materials from China to meet the growing requirements of drug formulations is a cause ...
Read more: Govt working on plan to raise API production to cut Chinese dependence: Comm Min report

Monday, October 8, 2018

Pharma Reviews: Gujarat pharma industry says business as usual, but seeks govt action against attacks on migrant ...

The mass exodus of fear-gripped North Indian migrant workers from Gujarat, in the wake of threats and attacks, may create problems for the pharma ...
Read more: Gujarat pharma industry says business as usual, but seeks govt action against attacks on migrant ...

Pharma Reviews: 3-Point Analysis | Will China's crackdown on drug manufacturers impact India?

The Chinese government is cracking down on thousands of pharma factories to check pollution and raise safety standards in the country. While this is ...
Read more: 3-Point Analysis | Will China's crackdown on drug manufacturers impact India?

Friday, October 5, 2018

Pharma Reviews: Russia May Increase Oil Production to Stabilise Global Prices After Modi-Putin Meet

Putin also mooted the possibility of a private partnership of Indian entities to explore Arctic gas, the official said. ... On his part, Modi highlighted the IT industry and pharma industry and hope the Russian market will be substantially ...
Read more: Russia May Increase Oil Production to Stabilise Global Prices After Modi-Putin Meet

Pharma Reviews: Pharma, Railways and infrastructure key areas of cooperation between India and Russia

India and Russia welcomed the establishment of a pharmaceutical plant by Advance Pharma Company in Russia. The Indian Side conveyed its ...
Read more: Pharma, Railways and infrastructure key areas of cooperation between India and Russia

Pharma Reviews: Enhancing Affordable Pharmaceutical Healthcare

There are noticeable growth surges, especially in key sectors such as pharmaceuticals (India is frequently referred to as the “global generics capital”), ...
Read more: Enhancing Affordable Pharmaceutical Healthcare

US FDA News: FDA allows marketing of first self-fitting hearing aid controlled by the user

FDA allows marketing of a new device, the Bose Hearing Aid, intended to amplify sounds for individuals 18 years or older with perceived mild to moderate hearing impairment (hearing loss). This is the first hearing aid authorized for marketing by the FDA that enables the user to fit, program and control the hearing aid on his or her own, without assistance from a health care provider.
Read more: FDA allows marketing of first self-fitting hearing aid controlled by the user

Thursday, October 4, 2018

Pharma Reviews: US may dilute norm used to delay generics

(q) of the US Federal Food, Drug and Cosmetic Act to delay the launch of ... But in the last three years quality issues in Indian manufacturing plants ...
Read more: US may dilute norm used to delay generics

Wednesday, October 3, 2018

Pharma Reviews: Pharma Startup Elbrit Life Sciences Raises $3 Mn from Its Parent & Qatar-based Investment Firm

The fast growing domestic pharmaceutical company is presently in ... He added that the company majorly operates in South India and has sales force ...
Read more: Pharma Startup Elbrit Life Sciences Raises $3 Mn from Its Parent & Qatar-based Investment Firm

Pharma Reviews: What next on the Agenda?

India also has one of the highest tariff rates when it comes to pharmaceutical import. India is at the top (or more properly, bottom) five offenders on drug ...
Read more: What next on the Agenda?

Tuesday, October 2, 2018

Pharma Reviews: India Must Move Beyond IPR-Protection to Focus on Better Health Outcomes

A lack of a strong IPR regime and drug price control – India is already ... The value of global export in pharmaceutical items has grown from $228 ...
Read more: India Must Move Beyond IPR-Protection to Focus on Better Health Outcomes

Pharma Reviews: Fake medicines: Here's Niti Aayog, Apollo Hospital, Oracle & Pharma sciences blockchain fix

The problem of fake and counterfeit drugs is a major issue, costing the Indian pharma industry billions of rupees, said Amitabh Kant, CEO, NITI Aayog.
Read more: Fake medicines: Here's Niti Aayog, Apollo Hospital, Oracle & Pharma sciences blockchain fix

Pharma Reviews: Meet the man giving tough time to Indian IT companies in the US

Kotchen did not start out to lead a crusade against Indian IT companies. ... At the FTC, he was part of investigations into pharmaceutical companies ...
Read more: Meet the man giving tough time to Indian IT companies in the US

Pharma Reviews: Daniel Kotchen: Man behind legal threats to Indian IT firewall

If Kotchen wins, not only could he cost Indian outsourcing companies ... At the FTC, he was part of investigations into pharmaceutical companies and ...
Read more: Daniel Kotchen: Man behind legal threats to Indian IT firewall

Monday, October 1, 2018

Pharma Reviews: China fuels drug fears

A crackdown on environmental pollution by China and inaction by the Indian government on industry pleas to revive the weakened domestic ...
Read more: China fuels drug fears

Pharma Reviews: Pharma, food processing, textiles under focus to boost Indian exports

The Commerce Ministry is focusing on nine sectors, including pharma, food processing and textiles, to boost exports in the current fiscal, an official ...
Read more: Pharma, food processing, textiles under focus to boost Indian exports

Pharma Reviews: India-Uzbekistan sign 17 agreements including visa-free travel, military edu

India and Uzbekistan inked 17 agreements on Monday including in military education and visa-free travel for diplomatic passport holders. ... nations agreed to collaborate with each other across sectors with special focus on pharma.
Read more: India-Uzbekistan sign 17 agreements including visa-free travel, military edu